Silibinin Up-regulates DNA-Protein Kinase-dependent p53 Activation to Enhance UVB-induced Apoptosis in Mouse Epithelial JB6 Cells
Authors:
- Chapla AgarwalCAChapla Agarwal
- Rana P. SinghRSRana P. Singh
- Rajesh AgarwalRARajesh Agarwal
Open Access
- 1 May 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (21) , 20375-20383
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Silibinin Protects against Photocarcinogenesis via Modulation of Cell Cycle Regulators, Mitogen-Activated Protein Kinases, and Akt SignalingCancer Research, 2004
- Role of DNA–PK in the cellular response to DNA double-strand breaksDNA Repair, 2004
- Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cellsBiochemical and Biophysical Research Communications, 2004
- UVA-mediated activation of signaling pathways involved in skin tumor promotion and progressionSeminars in Cancer Biology, 2004
- Dual efficacy of silibinin in protecting or enhancing ultraviolet B radiation-caused apoptosis in HaCaT human immortalized keratinocytesCarcinogenesis, 2003
- ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responsesCarcinogenesis, 2003
- Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosisCarcinogenesis, 2002
- Cell cycle checkpoint signaling through the ATM and ATR kinasesGenes & Development, 2001
- Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1? expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotionMolecular Carcinogenesis, 1999
- Protective Effects of Silymarin Against Photocarcinogenesis in a Mouse Skin ModelJNCI: Journal of the National Cancer Institute, 1997